Chromos and Genitope Corporation sign cell line engineering contract
Advertisement
Chromos Molecular Systems Inc. announced that it has entered into a cell line engineering service agreement with Genitope Corporation to develop a cell line using Chromos' ACE System for potential use in the clinical and commercial manufacture of a biopharmaceutical product.
Under the agreement, Chromos will engineer cell lines for the expression of a monoclonal antibody for Genitope using the ACE System. The financial details of the agreement were not disclosed.